Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Piramal Pharma Limited’s Pharma Solutions business announced that the company’s site in Digwal in the state of Telangana, India, has implemented various tools to unlock Active Pharmaceutical Ingredient (API) manufacturing capacity and support client ...
read more
Piramal has entered into an agreement with G&W Laboratories to acquire its solid oral dosage drug product manufacturing facility located in Sellersville, Pennsylvania.
read more
Tuesday, December 08, 2020
Piramal Pharma Limited has announced plans to expand its facility in Michigan with additional capacity and new capabilities for the development and manufacturing of APIs.
read more
Tuesday, October 10, 2017
Piramal announced investments of $55 million across its sites in North America & Asia, to expand its API manufacturing capabilities and capacities.
read more
Monday, December 08, 2014
This award is recognition of both Pierre Fabre's expertise in dermatology, one of its development priorities, and of its ability to form public-private partnerships, such as that established with the University of Bordeaux.
read more
Wednesday, November 29, 2017
Phyton Biotech has received a grant from the Bill & Melinda Gates Foundation to fund research and development of an alternative method of producing artemisinin.
read more
Tuesday, November 07, 2017
PharmaMar announced a licensing agreement with Boryung Pharm to commercialize the marine-derived anticancer drug Zepsyre, if approved, in South Korea.
read more
Tuesday, January 28, 2020
PharmaMar and Bionical Emas have announced the launch of an EAP for lurbinectedin to treat patients in the United States with relapsed SCLC, who are unable to enter clinical trials and there are no appropriate alternative treatments.
read more
Thursday, October 31, 2024
PharmaLogic Holdings Corp. announced the official opening of its radiopharmaceutical production and research facility in Los Angeles, California.
read more
Pharmaceutics International, Inc. (Pii), a contract development and manufacturing organization specializing in the development of difficult to formulate compounds, announced today that it has made a grant to the University of Mississippi (UM). The ...
read more
Pfizer and BioNTech announced the companies have agreed to a letter of intent regarding the co-development and distribution of a potential mRNA-based coronavirus vaccine aimed at preventing COVID-19 infection.
read more
Wednesday, November 18, 2020
Pfizer and BioNTech have announced their mRNA-based COVID-19 vaccine candidate, BNT162b2, met all of the study’s primary efficacy endpoints.
read more
Wednesday, December 02, 2020
Pfizer and BioNTech announced the MHRA in the U.K. has granted a temporary authorization for emergency use for their COVID-19 mRNA vaccine against COVID-19.
read more
Tuesday, December 29, 2015
Pfizer Inc. today announced that it has completed its acquisition of Hospira, Inc.
read more
Wednesday, March 07, 2018
Pfizer CentreOne announced the introduction of Enviero progesterone into the API marketplace.
read more